Sarkizova, Siranush
Klaeger, Susan http://orcid.org/0000-0002-0074-5163
Le, Phuong M.
Li, Letitia W.
Oliveira, Giacomo
Keshishian, Hasmik
Hartigan, Christina R.
Zhang, Wandi
Braun, David A.
Ligon, Keith L.
Bachireddy, Pavan
Zervantonakis, Ioannis K. http://orcid.org/0000-0003-2386-9553
Rosenbluth, Jennifer M. http://orcid.org/0000-0003-1314-6976
Ouspenskaia, Tamara
Law, Travis http://orcid.org/0000-0002-7399-3299
Justesen, Sune
Stevens, Jonathan
Lane, William J. http://orcid.org/0000-0002-1097-5229
Eisenhaure, Thomas
Lan Zhang, Guang
Clauser, Karl R.
Hacohen, Nir http://orcid.org/0000-0002-2349-2656
Carr, Steven A. http://orcid.org/0000-0002-7203-4299
Wu, Catherine J. http://orcid.org/0000-0002-3348-5054
Keskin, Derin B. http://orcid.org/0000-0002-8496-6181
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Human Genome Research Institute (T32HG002295)
Article History
Received: 28 May 2019
Accepted: 24 October 2019
First Online: 16 December 2019
Competing interests
: D.B.K. has previously advised Neon Therapeutics, and owns equity in Aduro Biotech, Agenus Inc., Armata Pharmaceuticals, Biomarin Pharmaceutical Inc., Bristol–Myers Squibb Com., Celldex Therapeutics Inc., Editas Medicine Inc., Exelixis Inc., Gilead Sciences Inc., IMV Inc., Lexicon Pharmaceuticals Inc. and Stemline Therapeutics Inc. D.A.B. has received consulting fees from Octane Global, Defined Health, Dedham Group, Adept Field Solutions, Slingshot Insights, Blueprint Partnership, Charles River Associates, Trinity Group and Insight Strategy, and is a member of the RCC translational medicine advisory broad of Bristol–Myers Squibb. K.L.L. owns equity and is a founder of Travera LLC and is an advisor to Bristol–Myers Squibb Com. and Rarecyte. S.A.C. is a member of the scientific advisory boards of Kymera, PTM BioLabs and BioAnalytix and a scientific advisor to Pfizer and Biogen. C.J.W. and N.H. are founders of Neon Therapeutics and members of its scientific advisory board. N.H. is also an advisor for IFM therapeutics. W.J.L. is a member of the scientific advisory board of CareDx. All other authors have no competing interests. Patent applications have been filed on aspects of the described work entitled as follows: ‘HLA single allele lines’, and ‘Methods for identifying neoantigens’.